Published 2016 | Version v1
Publication

Biosimilars in immune-mediated inflammatory diseases: initial lessons from the first approved biosimilar anti-tumour necrosis factor monoclonal antibody

Additional details

Identifiers

URL
http://hdl.handle.net/11567/848543
URN
urn:oai:iris.unige.it:11567/848543

Origin repository

Origin repository
UNIGE